Allergy Therapeutics plc (AIM:AGY)
London · Delayed Price · Currency is GBP · Price in GBX 11.00
-0.30 (-2.65%)
At close: Dec 31, 2025
Allergy Therapeutics Market Cap
Allergy Therapeutics has a market cap or net worth of 675.56 million as of December 31, 2025. Its market cap has increased by 121.46% in one year.
Market Cap
675.56M
Enterprise Value
722.86M
Revenue
55.04M
Ranking
n/a
PE Ratio
n/a
Stock Price
11.00
Market Cap Chart
Since October 11, 2004, Allergy Therapeutics's market cap has increased from 30.57M to 675.56M, an increase of 2,109.91%. That is a compound annual growth rate of 15.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 31, 2025 | 675.56M | 118.05% |
| Dec 31, 2024 | 309.82M | 160.00% |
| Dec 29, 2023 | 119.16M | 180.75% |
| Dec 30, 2022 | 42.44M | -79.49% |
| Dec 31, 2021 | 206.98M | 94.57% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 213.19B |
| GSK plc | 73.15B |
| Haleon | 33.22B |
| Smith & Nephew | 10.43B |
| Convatec Group | 4.74B |
| Hikma Pharmaceuticals | 3.40B |
| Genus | 1.73B |
| HUTCHMED (China) | 1.71B |